Paper41007697
Anti-Nuclear Antibody (ANA) Positivity and Nuclear Antigen Reactivity in Patients with Joint Hypermobility Syndrome/Hypermobile Ehlers Danlos Syndrome (JHS/hEDS).
Moy L and 2 others. Biomedicines, 2025. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Anti-Nuclear Antibody (ANA) Positivity and Nuclear Antigen Reactivity in Patients with Joint Hypermobility Syndrome/Hypermobile Ehlers Danlos Syndrome (JHS/hEDS). Papers, record 41007697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41007697
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Anti-Nuclear Antibody (ANA) Positivity and Nuclear Antigen Reactivity in Patients with Joint Hypermobility Syndrome/Hypermobile Ehlers Danlos Syndrome (JHS/hEDS).
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| K23 AR082966 | NIAMS NIH HHS | United States | K23AR082966 | PubMed and NIH |
Source NIH RePORTER
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39,996,015 | An evaluation of practices and policies used in genetics clinics across the United States to manage referrals for Ehlers-Danlos and hypermobility syndromes. | Genet Med Open | 2025 | https://conductscience.org/library/papers/39996015 | PubMed |
| 2 | 40,002,916 | Fibromyalgia, Depression, and Autoimmune Disorders: An Interconnected Web of Inflammation. | Biomedicines | 2025 | https://conductscience.org/library/papers/40002916 | PubMed |
| 3 | 31,267,471 | The Relationship Between Hypermobile Ehlers-Danlos Syndrome (hEDS), Postural Orthostatic Tachycardia Syndrome (POTS), and Mast Cell Activation Syndrome (MCAS). | Clin Rev Allergy Immunol | 2020 | https://conductscience.org/library/papers/31267471 | PubMed |
| 4 | 29,891,041 | Spectrum of Gastrointestinal Manifestations in Joint Hypermobility Syndromes. | Am J Med Sci | 2018 | https://conductscience.org/library/papers/29891041 | PubMed |
| 5 | 10,895,386 | Fibromyalgia syndrome: experience in a pediatric rheumatology clinic. | Clin Exp Rheumatol | 2000 | https://conductscience.org/library/papers/10895386 | PubMed |
| 6 | 35,366,287 | New Clinical Phenotype of the Post-Covid Syndrome: Fibromyalgia and Joint Hypermobility Condition. | Pathophysiology | 2022 | https://conductscience.org/library/papers/35366287 | PubMed |
| 7 | 33,479,068 | Beyond bones: The relevance of variants of connective tissue (hypermobility) to fibromyalgia, ME/CFS and controversies surrounding diagnostic classification: an observational study. | Clin Med (Lond) | 2021 | https://conductscience.org/library/papers/33479068 | PubMed |
| 8 | 31,685,018 | Fatigue severity in anti-nuclear antibody-positive individuals does not correlate with pro-inflammatory cytokine levels or predict imminent progression to symptomatic disease. | Arthritis Res Ther | 2019 | https://conductscience.org/library/papers/31685018 | PubMed |
| 9 | 35,210,816 | The Role of Clinical Features and Serum Biomarkers in Identifying Patients with Incomplete Lupus Erythematosus at Higher Risk of Transitioning to Systemic Lupus Erythematosus: Current Perspectives. | J Inflamm Res | 2022 | https://conductscience.org/library/papers/35210816 | PubMed |
| 10 | 28,306,229 | The 2017 international classification of the Ehlers-Danlos syndromes. | Am J Med Genet C Semin Med Genet | 2017 | https://conductscience.org/library/papers/28306229 | PubMed |
| 11 | 4,751,776 | Articular mobility in an African population. | Ann Rheum Dis | 1973 | https://conductscience.org/library/papers/4751776 | PubMed |
| 12 | 28,145,606 | A framework for the classification of joint hypermobility and related conditions. | Am J Med Genet C Semin Med Genet | 2017 | https://conductscience.org/library/papers/28145606 | PubMed |
| 13 | 39,451,569 | Decoding the Genetic Basis of Mast Cell Hypersensitivity and Infection Risk in Hypermobile Ehlers-Danlos Syndrome. | Curr Issues Mol Biol | 2024 | https://conductscience.org/library/papers/39451569 | PubMed |
| 14 | 28,286,166 | Joint Hypermobility Syndrome: Recognizing a Commonly Overlooked Cause of Chronic Pain. | Am J Med | 2017 | https://conductscience.org/library/papers/28286166 | PubMed |
| 15 | 3,487,650 | A prospective evaluation of 118 patients with the fibromyalgia syndrome: prevalence of Raynaud's phenomenon, sicca symptoms, ANA, low complement, and Ig deposition at the dermal-epidermal junction. | J Rheumatol | 1986 | https://conductscience.org/library/papers/3487650 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41007697
GET https://conductscience.org/api/papers/v1/41007697/authors